Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
- 31 July 2007
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 197 (1), 28.e1-28.e6
- https://doi.org/10.1016/j.ajog.2007.04.010
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaNew England Journal of Medicine, 2006
- Soluble endoglin contributes to the pathogenesis of preeclampsiaNature Medicine, 2006
- Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2005
- Latest Advances in Understanding PreeclampsiaScience, 2005
- Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant WomenHypertension Research, 2005
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Diagnosis and Management of Gestational Hypertension and PreeclampsiaObstetrics & Gynecology, 2003
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in PregnancyAmerican Journal of Obstetrics and Gynecology, 2000
- The myths of laparoscopic surgeryAmerican Journal of Obstetrics and Gynecology, 2000
- Pregnancy outcomes in healthy nulliparas who developed hypertensionObstetrics & Gynecology, 2000